Boston Scientific Corporation: Stroke trials
The registry lists 14 Stroke studies with Boston Scientific Corporation as lead sponsor. 1 are open to participants now and 7 have results posted.
Phase 2 1Phase 3 3No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Elite AF IDE Trial (Elite AF)RecruitingNCT07287436Not applicable
- HEAL-LAA Clinical TrialCompletedNCT05809596Not applicableResults posted
- WATCHMAN FLX™ CT StudyCompletedNCT05324371Not applicableResults posted
- PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve ReplacementCompletedNCT04149535Not applicableResults posted
- Assessment of the WATCHMAN™ Device in Patients Unsuitable for Oral AnticoagulationTerminatedNCT02928497Not applicableResults posted
- Registry on WATCHMAN Outcomes in Real-Life UtilizationCompletedNCT01972282Results posted
- Evaluation of the WATCHMAN Left Atrial Appendage (LAA) Closure Device in Patients With Atrial Fibrillation Versus Long Term Warfarin TherapyCompletedNCT01182441Phase 3Results posted
- WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients With Atrial FibrillationCompletedNCT00129545Phase 2/3Results posted
- SIMPLAAFY Clinical TrialActive, not recruitingNCT06521463Not applicable
- CHAMPION-AF Clinical TrialActive, not recruitingNCT04394546Not applicable
- Evaluation of the Next Generation WATCHMAN LAA Closure Technology in Non-Valvular AF Patients (EVOLVE)CompletedNCT01196897Not applicable
- Adapt Monorail Carotid Stent System: A Postmarket Clinical Follow-up StudyCompletedNCT01133327Not applicable
- Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZ™ and the EndoTex™ NexStent™CompletedNCT00600327Phase 3
- Boston Scientific Embolic Protection, Inc. (EPI): A Carotid Stenting Trial for High-Risk Surgical Patients (BEACH)CompletedNCT00316108Not applicable